The progression to a dilated phase in hypertrophic cardiomyopathy is associated with non-uniform massive fibrosis linked to small-arterial lesions.
Authors
No takes yet. Share an insight, caveat, or question.
Supports fibrosis as progression marker in HCM; hypothesis-generating and requires prospective validation before clinical use.
Kawashima et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: